337
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Diagnostic implications of loss of 5-hydroxymethylcytosine for melanoma

&
Pages 99-101 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jane M Grant-Kels. (2013) The diagnosis of melanoma. Expert Review of Dermatology 8:2, pages 95-97.
Read now

Articles from other publishers (4)

I. Anestopoulos, S. Kyriakou, V. Tragkola, I. Paraskevaidis, E. Tzika, M. Mitsiogianni, M.V. Deligiorgi, G. Petrakis, D.T. Trafalis, S. Botaitis, A. Giatromanolaki, M.I. Koukourakis, R. Franco, A. Pappa & M.I. Panayiotidis. (2022) Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises. Pharmacology & Therapeutics 240, pages 108301.
Crossref
Weimin Guo, Ting Xu, Jonathan J Lee, George F Murphy & Christine G Lian. (2015) Epigenetic markers in melanoma. Melanoma Management 2:4, pages 367-382.
Crossref
Allison R Larson, Karen A Dresser, Qian Zhan, Cecilia Lezcano, Bruce A Woda, Benafsha Yosufi, John F Thompson, Richard A Scolyer, Martin C MihmJrJr, Yujiang G Shi, George F Murphy & Christine Guo Lian. (2014) Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors. Modern Pathology 27:7, pages 936-944.
Crossref
Ioannis Anestopoulos, Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Eleni Tzika, Melina Mitsiogianni, Maria Deligiorgi, Giorgos Petrakis, Dimitrios T. Trafalis, Sotiris Botaitis, Alexandra Giatromanolaki, Michail I. Koukourakis, Franco Rodrigo, Aglaia Pappa & Mihalis Panagiotidis. (2022) Targeting the Epigenome in Malignant Melanoma: Facts, Challenges and Therapeutic Promises. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.